Research presented at the International Conference on Molecular Targets and Cancer Therapeutics this week in Boston could point the way to new therapies to treat pancreatic cancer. Pancreatic cancer has long remained one of the toughest targets in the oncology drug field. It is a deadly type of cancer with an overall 5-year survival rate […]
↧